— Know what they know.
Not Investment Advice
Also trades as: ARAY (NASDAQ) · $vol 0M

0H8I.L LSE

Accuray Incorporated
1W: +11.9% 1M: -26.5% 3M: -41.5% YTD: -46.4% 1Y: -81.4% 3Y: -92.7%
$0.31
+0.00 (+0.00%)
 
Weekly Expected Move ±24.5%
$0 $0 $0 $0 $0
LSE · Healthcare · Medical - Devices · Alpha Radar Sell · Power 36 · $36.8M mcap · 113M float · 0.0005% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$36.8M
52W Range0.304-4.2614
Volume905
Avg Volume564
Beta1.43
Dividend
Analyst Ratings
2 Buy 3 Hold 1 Sell
Consensus Hold
Company Info
CEOStephen R. LaNeve
Employees987
SectorHealthcare
IndustryMedical - Devices
IPO Date2018-01-29
1310 Chesapeake Terrace
Madison, CA 94089
US
408 716 4600
About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms